{"id":27235,"date":"2022-12-12T14:31:42","date_gmt":"2022-12-12T13:31:42","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=27235"},"modified":"2023-06-06T16:22:14","modified_gmt":"2023-06-06T15:22:14","slug":"strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/","title":{"rendered":"Strat\u00e9gie d&#8217;acc\u00e9l\u00e9ration MIE-MN &#8211; Liste des pathog\u00e8nes prioritaires"},"content":{"rendered":"\n<p>L\u2019ANRS | Maladies infectieuses \u00e9mergentes a travaill\u00e9 \u00e0 l\u2019\u00e9laboration d\u2019une liste de familles de pathog\u00e8nes ayant un fort risque de d\u00e9clencher une crise naturelle, accidentelle ou provoqu\u00e9e, afin de concentrer les efforts de pr\u00e9paration de la France dans le cadre de la strat\u00e9gie d\u2019acc\u00e9l\u00e9ration MIE-MN.<\/p>\n\n\n\n<div style=\"height:32px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Dans cette liste figurent 6 types de bact\u00e9ries dont deux r\u00e9sistantes  : <\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"604\" height=\"454\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4.png\" alt=\"\" class=\"wp-image-27237\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4.png 604w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4-300x225.png 300w\" sizes=\"(max-width: 604px) 100vw, 604px\" \/><\/figure>\n\n\n\n<div style=\"height:31px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Les maladies infectieuses \u00e9mergentes ou r\u00e9-\u00e9mergentes sont une priorit\u00e9 de sant\u00e9 publique. L\u2019exemple r\u00e9cent de la pand\u00e9mie de Covid-19 est l\u2019illustration concr\u00e8te de l\u2019impact de ces maladies sur la sant\u00e9 mais aussi sur les \u00e9conomies et les soci\u00e9t\u00e9s.&nbsp;<\/p>\n\n\n\n<p>Dans ce contexte, la mise en place de projets de recherche ambitieux est indispensable pour mieux comprendre, pr\u00e9venir et contr\u00f4ler les ph\u00e9nom\u00e8nes d\u2019\u00e9mergence des maladies infectieuses, mais \u00e9galement d\u00e9velopper des contre-mesures pour diagnostiquer, prot\u00e9ger ou traiter les individus. Ainsi, une r\u00e9ponse globale et int\u00e9gr\u00e9e pourra \u00eatre mise en place pour limiter leurs impacts.&nbsp;<\/p>\n\n\n\n<div style=\"height:38px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Pour faire face \u00e0 ces enjeux, la France s\u2019est dot\u00e9e d\u2019une <a href=\"https:\/\/www.gouvernement.fr\/maladies-infectieuses-emergentes-menaces-nucleaires-radiologiques-biologiques-et-chimiques\">Strat\u00e9gie nationale d\u2019acc\u00e9l\u00e9ration &#8220;Maladies infectieuses \u00e9mergentes et Menaces nucl\u00e9aires, radiologiques, biologiques et chimiques&#8221; (MIE-MN)<\/a> dans le cadre de France 2030. &nbsp;<\/p>\n\n\n\n<p>Le socle scientifique de la strat\u00e9gie est constitu\u00e9 par deux Programmes et Equipements Prioritaires de Recherche (PEPR) compl\u00e9mentaires et qui seront mis en \u0153uvre en \u00e9troite collaboration sur 5 ans :<\/p>\n\n\n\n<ul><li>Un PEPR MIE, qui porte sur la pr\u00e9vention et le contr\u00f4le des maladies infectieuses \u00e9mergentes. Il est dot\u00e9 de 80 millions d\u2019euros et pilot\u00e9 par l\u2019ANRS | Maladies infectieuses \u00e9mergentes, en articulation avec l\u2019ensemble de ses partenaires acad\u00e9miques fran\u00e7ais ;<\/li><li>Un second consacre 30 millions d\u2019euros \u00e0 la pr\u00e9vention des \u00e9mergences zoonotiques (virus, bact\u00e9rie ou parasites transmis aux humains par des animaux ou des insectes). Il s\u2019inscrit dans l\u2019initiative internationale <a href=\"https:\/\/prezode.org\/prezode_fre\/\">PREZODE<\/a> et est pilot\u00e9 par le CIRAD, l\u2019INRAE et l\u2019IRD.<\/li><\/ul>\n\n\n\n<div style=\"height:48px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><a href=\"https:\/\/www.anrs.fr\/fr\/emergences\/enjeux-de-la-recherche\/pepr-maladies-infectieuses-emergentes\">Plus d&#8217;informations sur le site de l&#8217;ANRS | Maladies infectieuses \u00e9mergentes<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019ANRS | Maladies infectieuses \u00e9mergentes a travaill\u00e9 \u00e0 l\u2019\u00e9laboration d\u2019une liste de familles de pathog\u00e8nes ayant un fort risque de d\u00e9clencher une crise naturelle, accidentelle ou provoqu\u00e9e, afin de concentrer les efforts de pr\u00e9paration de la France dans le cadre de la strat\u00e9gie d\u2019acc\u00e9l\u00e9ration MIE-MN. Dans cette liste figurent 6 types de bact\u00e9ries dont deux [&hellip;]<\/p>\n","protected":false},"author":271,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[6629,6579,6581],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Strat\u00e9gie d&#039;acc\u00e9l\u00e9ration MIE-MN - Liste des pathog\u00e8nes prioritaires - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Strat\u00e9gie d&#039;acc\u00e9l\u00e9ration MIE-MN - Liste des pathog\u00e8nes prioritaires - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-12T13:31:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-06T15:22:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4.png\" \/>\n<meta name=\"author\" content=\"Loane Serrano\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Loane Serrano\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/\"},\"author\":{\"name\":\"Loane Serrano\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/7993978f184ff491165415f02259de61\"},\"headline\":\"Strat\u00e9gie d&#8217;acc\u00e9l\u00e9ration MIE-MN &#8211; Liste des pathog\u00e8nes prioritaires\",\"datePublished\":\"2022-12-12T13:31:42+00:00\",\"dateModified\":\"2023-06-06T15:22:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/\"},\"wordCount\":359,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4.png\",\"keywords\":[\"AAP\",\"antimicrobial\",\"resistance\"],\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/\",\"name\":\"Strat\u00e9gie d'acc\u00e9l\u00e9ration MIE-MN - Liste des pathog\u00e8nes prioritaires - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4.png\",\"datePublished\":\"2022-12-12T13:31:42+00:00\",\"dateModified\":\"2023-06-06T15:22:14+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Strat\u00e9gie d\u2019acc\u00e9l\u00e9ration MIE-MN \u2013 Liste des pathog\u00e8nes prioritaires\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/7993978f184ff491165415f02259de61\",\"name\":\"Loane Serrano\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Strat\u00e9gie d'acc\u00e9l\u00e9ration MIE-MN - Liste des pathog\u00e8nes prioritaires - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/","og_locale":"fr_FR","og_type":"article","og_title":"Strat\u00e9gie d'acc\u00e9l\u00e9ration MIE-MN - Liste des pathog\u00e8nes prioritaires - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2022-12-12T13:31:42+00:00","article_modified_time":"2023-06-06T15:22:14+00:00","og_image":[{"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4.png"}],"author":"Loane Serrano","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Loane Serrano","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/"},"author":{"name":"Loane Serrano","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/7993978f184ff491165415f02259de61"},"headline":"Strat\u00e9gie d&#8217;acc\u00e9l\u00e9ration MIE-MN &#8211; Liste des pathog\u00e8nes prioritaires","datePublished":"2022-12-12T13:31:42+00:00","dateModified":"2023-06-06T15:22:14+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/"},"wordCount":359,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4.png","keywords":["AAP","antimicrobial","resistance"],"articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/","name":"Strat\u00e9gie d'acc\u00e9l\u00e9ration MIE-MN - Liste des pathog\u00e8nes prioritaires - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4.png","datePublished":"2022-12-12T13:31:42+00:00","dateModified":"2023-06-06T15:22:14+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2022\/12\/image-4.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/strategie-dacceleration-mie-mn-liste-des-pathogenes-prioritaires\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"Strat\u00e9gie d\u2019acc\u00e9l\u00e9ration MIE-MN \u2013 Liste des pathog\u00e8nes prioritaires"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/7993978f184ff491165415f02259de61","name":"Loane Serrano"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-20 02:55:45","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/27235"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/271"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=27235"}],"version-history":[{"count":3,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/27235\/revisions"}],"predecessor-version":[{"id":27247,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/27235\/revisions\/27247"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=27235"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=27235"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=27235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}